Bowen's Disease

What is it?

Bowen's disease is squamous cell carcinoma "in situ," meaning it is an early form of skin cancer confined to the outermost layer of skin (epidermis) that has not yet invaded deeper tissues. Named after dermatologist John T. Bowen who first described it in 1912, this condition appears as persistent, scaly red patches on sun-exposed skin. While it grows slowly and remains non-invasive for years, approximately 3-5% of untreated cases eventually progress to invasive squamous cell carcinoma, making early treatment important.

Who is affected?

Bowen's disease primarily affects older adults with significant sun exposure history.

• Prevalence: Annual incidence of 14.9 per 100,000 in the United States; accounts for 2-3% of all dermatology referrals
• Age demographics: Peak incidence in the 70s and 80s; average age at diagnosis is 70 years; rare before age 30 unless immunosuppressed
• Gender distribution: Historically more common in women (60-70% of cases), though recent studies show equalizing rates
• Skin type predisposition: Predominantly affects fair-skinned individuals (Fitzpatrick types I-III); less common in darker skin types
• Risk factors: Chronic sun exposure; history of sunburns; arsenic exposure; immunosuppression (organ transplant recipients have 65-fold increased risk); HPV infection (especially genital Bowen's); radiation therapy

What causes it?

Multiple factors contribute to the development of this precancerous condition:

• UV radiation damage: Cumulative sun exposure is primary cause; UV-induced mutations in p53 tumor suppressor gene; explains predominance on sun-exposed sites
• Human papillomavirus (HPV): HPV types 16, 18, 31, 33 detected in 30-80% of genital cases; role in non-genital disease less clear but may be cofactor
• Chemical carcinogens: Historical arsenic exposure (medicinal tonics, contaminated water); may appear decades after exposure; often multiple lesions
• Immunosuppression: Organ transplant recipients, HIV patients at increased risk; impaired immune surveillance allows abnormal cells to proliferate
• Other factors: Previous radiation therapy; chronic inflammation or scarring; genetic susceptibility in some cases

What are the clinical features?

Bowen's disease presents as persistent, slowly enlarging patches with characteristic features:

• Classic appearance: Well-demarcated, red or pink scaly patch or thin plaque; irregular borders but sharply defined edges; surface appears velvety, crusted, or hyperkeratotic (thickened)
• Size and growth: Usually 1-3 cm at diagnosis but can be larger; grows slowly over months to years; may remain stable for long periods
• Location patterns: Sun-exposed areas most common - lower legs (60-85% in women), head and neck (especially in men); hands and fingers; can occur on covered areas including genitals
• Variations: Pigmented Bowen's - brown or black, more common in darker skin; verrucous type - warty appearance; erythroplasia of Queyrat - Bowen's disease of glans penis or vulva
• Symptoms: Usually asymptomatic; occasional mild itching or tenderness; bleeding if traumatized; patients often think it's eczema or psoriasis

How is it diagnosed?

Diagnosis requires histopathological confirmation due to variable clinical appearance:

• Clinical examination: Dermoscopy reveals glomerular (coiled) vessels in 90% of cases; scaly surface with dotted vessels; helps distinguish from psoriasis, eczema
• Skin biopsy (essential): Shows full-thickness epidermal dysplasia; abnormal cells throughout epidermis but basement membrane intact; characteristic "windblown" appearance of cells
• Histopathologic features: Atypical keratinocytes with loss of normal maturation; hyperkeratosis, parakeratosis, acanthosis; intact basement membrane (key feature distinguishing from invasive SCC)
• Differential diagnosis: Must distinguish from psoriasis, chronic eczema, superficial basal cell carcinoma, actinic keratosis, tinea corporis
• Additional testing: Consider HPV testing for genital lesions; examine for multiple lesions if arsenic exposure suspected

What treatment options are available?

Treatment choice depends on location, size, patient factors, with excellent cure rates:

• Topical therapies (first-line for many): 5-fluorouracil cream - applied daily for 4-8 weeks, 85-95% clearance; imiquimod 5% - 3-5 times weekly for 12-16 weeks, 73-88% success; photodynamic therapy - 76-95% clearance, good cosmetic results
• Destructive methods: Cryotherapy - liquid nitrogen, 75-96% cure rate, simple but may scar; electrodesiccation and curettage - 93-98% success, requires local anesthesia
• Surgical excision: Standard excision with 4-5mm margins - 95-99% cure rate; Mohs micrographic surgery - for facial, digital, genital sites, >95% cure
• Radiation therapy: Reserved for elderly or poor surgical candidates; 95% local control but requires multiple visits
• Monitoring approach: Observation acceptable for very elderly with limited life expectancy; regular follow-up essential as 3-5% progress to invasive SCC
• Prognosis: Excellent with treatment - cure rates exceed 90% for most modalities; untreated - 3-5% progression to invasive SCC over years; 13-20% develop additional skin cancers within 5 years; recurrence rate 5-10% depending on treatment; regular skin surveillance recommended

Key points for patients

• Bowen's disease is early-stage skin cancer that hasn't spread - it's highly treatable
• Left untreated, a small percentage can become invasive cancer over many years
• Multiple effective treatments available with high cure rates exceeding 90%
• When to seek medical attention: Any persistent red, scaly patch lasting more than 2 months; patches that bleed, grow, or don't respond to moisturizers; new similar patches appearing
• Prevention: Sun protection is crucial - daily sunscreen, protective clothing; regular skin self-examinations; annual dermatology check-ups if history of skin cancer; avoid tanning beds